Kawakami Ayumi, Shibahashi Keita, Sugiyama Kazuhiro, Hifumi Toru, Inoue Akihiko, Sakamoto Tetsuya, Kuroda Yasuhiro
Tertiary Emergency Medical Center Tokyo Metropolitan Bokutoh Hospital Sumida-ku Tokyo Japan.
Department of Emergency and Critical Care Medicine St. Luke's International Hospital Tokyo Japan.
Acute Med Surg. 2024 Dec 20;11(1):e70021. doi: 10.1002/ams2.70021. eCollection 2024 Jan-Dec.
The optimal arterial partial pressure of carbon dioxide (PaCO) for patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR) remains unknown. We aimed to investigate the association between post-resuscitation PaCO and neurological outcomes.
This retrospective cohort study analyzed data from the Study of Advanced Life Support for Ventricular Fibrillation with Extracorporeal Circulation in Japan, a multicenter registry study across 36 hospitals in Japan, including patients with out-of-hospital cardiac arrest (OHCA) admitted to intensive care units (ICU) after ECPR between 2013 and 2018. Good PaCO management status was defined as a PaCO value of 35-45 mmHg. We classified patients into four groups (poor-poor, poor-good, good-poor, and good-good) according to their PaCO management status upon admission at the ICU and the following day. The primary outcome was a favorable neurological outcome, defined as cerebral performance category 1 or 2, 30 days after cardiac arrest. The secondary outcome was survival 30 days after cardiac arrest.
We classified 885 eligible patients into poor-poor ( = 361), poor-good ( = 231), good-poor ( = 155), and good-good ( = 138) groups. No significant association was observed between PaCO management and favorable 30-day neurological outcomes. Compared with the poor-poor group, the poor-good, good-poor, and good-good groups had adjusted odds ratios of 0.87 (95% confidence interval, 0.52-1.44), 1.17 (0.65-2.05), and 0.95 (0.51-1.73), respectively. The 30-day survival rates among the four groups did not differ significantly.
PaCO values were not significantly associated with 30-day neurological outcomes or survival of patients with OHCA after ECPR.
体外心肺复苏(ECPR)患者的最佳动脉血二氧化碳分压(PaCO₂)仍不清楚。我们旨在研究复苏后PaCO₂与神经功能预后之间的关联。
这项回顾性队列研究分析了日本体外循环心室颤动高级生命支持研究的数据,这是一项在日本36家医院开展的多中心注册研究,纳入了2013年至2018年间接受ECPR后入住重症监护病房(ICU)的院外心脏骤停(OHCA)患者。良好的PaCO₂管理状态定义为PaCO₂值为35 - 45 mmHg。我们根据患者入住ICU时及次日的PaCO₂管理状态将其分为四组(差 - 差、差 - 好、好 - 差和好 - 好)。主要结局是心脏骤停30天后良好的神经功能预后,定义为脑功能分类为1或2级。次要结局是心脏骤停30天后存活。
我们将885例符合条件的患者分为差 - 差组(n = 361)、差 - 好组(n = 231)、好 - 差组(n = 155)和好 - 好组(n = 138)。未观察到PaCO₂管理与30天良好神经功能预后之间存在显著关联。与差 - 差组相比,差 - 好组、好 - 差组和好 - 好组的校正比值比分别为0.87(95%置信区间,0.52 - 1.44)、1.17(0.65 - 2.05)和0.95(0.51 - 1.73)。四组的30天生存率无显著差异。
PaCO₂值与ECPR后OHCA患者的30天神经功能预后或生存率无显著关联。